glp 1 news Science's 2023 Breakthrough: GLP-1 Agonists Show Promise Against Obesity-Associated Disease GLP-1 Drug Overdoses Are on

Associated Press

According to FDA guidance, GLP-1 medications are not recommended for people who have: Pregnancy, because safety data are limited and pregnancy requires appropriate weight gain and nutrient storage A prior history of pancreatitis, due to a risk of triggering inflammation of the pancreas A history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2), a rare genetic condition linked to thyroid cancer in animal studies A clinician will review your medical history carefully to determine whether these medications are appropriate for you

Schwarz says the commentary is a call for disciplined use, not a warning against the class of medications

The field of GLP-1 medications continues to evolve rapidly

Morton also emphasizes that weight regain is not a personal failure

This is especially important considering the increasing use of these medications. The authors write that, to their knowledge, this is the first case detailing a patient developing this serious condition after starting tirzepatide for diabetes (in contrast to those treated with tirzepatide for weight loss)